102 related articles for article (PubMed ID: 29023897)
61. From squamous intraepithelial lesions to cervical cancer: Circulating microRNAs as potential biomarkers in cervical carcinogenesis.
Berti FCB; Salviano-Silva A; Beckert HC; de Oliveira KB; Cipolla GA; Malheiros D
Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188306. PubMed ID: 31398380
[TBL] [Abstract][Full Text] [Related]
62. Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors.
Zheng M; Hou L; Ma Y; Zhou L; Wang F; Cheng B; Wang W; Lu B; Liu P; Lu W; Lu Y
Mol Cancer; 2019 Apr; 18(1):76. PubMed ID: 30940131
[TBL] [Abstract][Full Text] [Related]
63. microRNAs: New prognostic, diagnostic, and therapeutic biomarkers in cervical cancer.
Nahand JS; Taghizadeh-Boroujeni S; Karimzadeh M; Borran S; Pourhanifeh MH; Moghoofei M; Bokharaei-Salim F; Karampoor S; Jafari A; Asemi Z; Tbibzadeh A; Namdar A; Mirzaei H
J Cell Physiol; 2019 Aug; 234(10):17064-17099. PubMed ID: 30891784
[TBL] [Abstract][Full Text] [Related]
64. Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1.
Zhou CF; Ma J; Huang L; Yi HY; Zhang YM; Wu XG; Yan RM; Liang L; Zhong M; Yu YH; Wu S; Wang W
Oncogene; 2019 Feb; 38(8):1256-1268. PubMed ID: 30254211
[TBL] [Abstract][Full Text] [Related]
65. Mifepristone Inhibits the Migration of Cervical Cancer Cells by Inhibiting Exocrine Secretion.
Sang L; Wang X; Zhao X
Pharmacology; 2018; 101(5-6):322-329. PubMed ID: 29621762
[TBL] [Abstract][Full Text] [Related]
66. Identification of E6/E7-Dependent MicroRNAs in HPV-Positive Cancer Cells.
Honegger A; Schilling D; Sültmann H; Hoppe-Seyler K; Hoppe-Seyler F
Methods Mol Biol; 2018; 1699():119-134. PubMed ID: 29086374
[TBL] [Abstract][Full Text] [Related]
67. Diagnostic potential of exosomal extracellular vesicles in oncology.
Andre M; Caobi A; Miles JS; Vashist A; Ruiz MA; Raymond AD
BMC Cancer; 2024 Mar; 24(1):322. PubMed ID: 38454346
[TBL] [Abstract][Full Text] [Related]
68. Exosomes in Cancer: Diagnostic and Therapeutic Applications.
Maqsood Q; Sumrin A; Saleem Y; Wajid A; Mahnoor M
Clin Med Insights Oncol; 2024; 18():11795549231215966. PubMed ID: 38249520
[TBL] [Abstract][Full Text] [Related]
69. Emerging roles of activating transcription factor (ATF) family members in tumourigenesis and immunity: Implications in cancer immunotherapy.
Chen M; Liu Y; Yang Y; Qiu Y; Wang Z; Li X; Zhang W
Genes Dis; 2022 Jul; 9(4):981-999. PubMed ID: 35685455
[TBL] [Abstract][Full Text] [Related]
70. Advances in exosome biomarkers for cervical cancer.
Ran Z; Wu S; Ma Z; Chen X; Liu J; Yang J
Cancer Med; 2022 Dec; 11(24):4966-4978. PubMed ID: 35578572
[TBL] [Abstract][Full Text] [Related]
71. Extracellular Vesicles: New Tools for Early Diagnosis of Breast and Genitourinary Cancers.
Testa A; Venturelli E; Brizzi MF
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445131
[TBL] [Abstract][Full Text] [Related]
72. Exosomes as Biomarkers for Female Reproductive Diseases Diagnosis and Therapy.
Esfandyari S; Elkafas H; Chugh RM; Park HS; Navarro A; Al-Hendy A
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671587
[TBL] [Abstract][Full Text] [Related]
73. The Role of Exosomes in the Female Reproductive System and Breast Cancers.
Bai Y; Guo J; Liu Z; Li Y; Jin S; Wang T
Onco Targets Ther; 2020; 13():12567-12586. PubMed ID: 33324075
[TBL] [Abstract][Full Text] [Related]
74. Synergies in exosomes and autophagy pathways for cellular homeostasis and metastasis of tumor cells.
Salimi L; Akbari A; Jabbari N; Mojarad B; Vahhabi A; Szafert S; Kalashani SA; Soraya H; Nawaz M; Rezaie J
Cell Biosci; 2020; 10():64. PubMed ID: 32426106
[TBL] [Abstract][Full Text] [Related]
75. The exosome-mediated PI3k/Akt/mTOR signaling pathway in cervical cancer.
Zhang W; Zhou Q; Wei Y; Da M; Zhang C; Zhong J; Liu J; Shen J
Int J Clin Exp Pathol; 2019; 12(7):2474-2484. PubMed ID: 31934074
[TBL] [Abstract][Full Text] [Related]
76. Alcohol Exposure Impacts the Composition of HeLa-Derived Extracellular Vesicles.
Jones LB; Kumar S; Curry AJ; Price JS; Krendelchtchikov A; Crenshaw BJ; Bell CR; Williams SD; Tolliver TA; Saldanha SN; Sims B; Matthews QL
Biomedicines; 2019 Sep; 7(4):. PubMed ID: 31574936
[TBL] [Abstract][Full Text] [Related]
77. The role of miRNAs in the invasion and metastasis of cervical cancer.
Wang JY; Chen LJ
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30833362
[TBL] [Abstract][Full Text] [Related]
78. Ras and exosome signaling.
Sexton RE; Mpilla G; Kim S; Philip PA; Azmi AS
Semin Cancer Biol; 2019 Feb; 54():131-137. PubMed ID: 30769101
[TBL] [Abstract][Full Text] [Related]
79. ATF1 and RAS in exosomes are potential clinical diagnostic markers for cervical cancer.
Shi Y; Wang W; Yang B; Tian H
Cell Biochem Funct; 2017 Oct; 35(7):477-483. PubMed ID: 29023897
[TBL] [Abstract][Full Text] [Related]
80. Radiation-induced increase in cell migration and metastatic potential of cervical cancer cells operates via the K-Ras pathway.
Su WH; Chuang PC; Huang EY; Yang KD
Am J Pathol; 2012 Feb; 180(2):862-71. PubMed ID: 22138581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
